
Takeda Pharmaceuticals, whose partner is Danish Lundbeck, surpassed analyst predictions in the first quarter, according to Bloomberg News.
In Q1, Takeda Pharmaceuticals had a revenue of JPY 949.60bn (USD 8.67bn).
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app